Glycosylation characteristics of colorectal cancer

Advances in Cancer Research

Volumn 126, Issue , 2015, Pages 203-256

  Holst, Stephanie ^a   Wuhrer, Manfred ^a,b,c   Rombouts, Yoann ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

(Sialyl) Lewis antigens; Colorectal cancer; Fucosylation; Glycosphingolipid glycans; Immunity modulation; Metastasis; N glycans; O glycans; Sialylation; Tumorigenesis

Indexed keywords

GLYCAN; GLYCOSPHINGOLIPID; GLYCOPROTEIN; TUMOR PROTEIN;

ARTICLE; BINDING ASSAY; BLOOD GROUP LEWIS SYSTEM; CARCINOGENESIS; COLORECTAL CANCER; FUCOSYLATION; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; IMMUNOMODULATION; MASS SPECTROMETRY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; SIALYLATION; SULFATION; THERAPY RESISTANCE; ANIMAL; COLORECTAL TUMOR; METABOLISM; PATHOLOGY;

ANIMALS; COLORECTAL NEOPLASMS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; NEOPLASM PROTEINS;

EID: 84923313064     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/bs.acr.2014.11.004     Document Type: Chapter

References (280)

1. Adamczyk B., Tharmalingam T., Rudd P.M. Glycans as cancer biomarkers. Biochimica et Biophysica Acta (BBA) - General Subjects 2012, 1820(9):1347-1353. doi:10.1016/j.bbagen.2011.12.001.
2. Ahn J., Bones J., Yu Y.Q., Rudd P.M., Gilar M. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2010, 878(3-4):403-408. 10.1016/j.jchromb.2009.12.013.
3. Aldredge D., An H.J., Tang N., Waddell K., Lebrilla C.B. Annotation of a serum N-glycan library for rapid identification of structures. Journal of Proteome Research 2012, 11(3):1958-1968. 10.1021/pr2011439.
4. An H.J., Gip P., Kim J., Wu S., Park K.W., McVaugh C.T., et al. Extensive determination of glycan heterogeneity reveals an unusual abundance of high mannose glycans in enriched plasma membranes of human embryonic stem cells. Molecular & Cellular Proteomics: MCP 2012, 11(4). M111 010660. http://dx.doi.org/0.1074/mcp.M111.010660.
5. Andersen D.C., Bridges T., Gawlitzek M., Hoy C. Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. Biotechnology and Bioengineering 2000, 70(1):25-31.
6. Anderson N.L., Razavi M., Pearson T.W., Kruppa G., Paape R., Suckau D. Precision of heavy-light peptide ratios measured by maldi-tof mass spectrometry. Journal of Proteome Research 2012, 11(3):1868-1878. 10.1021/pr201092v.
7. Apweiler R., Hermjakob H., Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta 1999, 1473(1):4-8.
8. Arfaoui-Toumi A., Kria-Ben Mahmoud L., Ben Hmida M., Khalfallah M.T., Regaya-Mzabi S., Bouraoui S. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients). Bulletin du Cancer 2010, 97(2):E1-E8. 10.1684/bdc.2010.1032.
9. Bai Y., Huang W., Ma L.T., Jiang J.L., Chen Z.N. Importance of N-glycosylation on CD147 for its biological functions. International Journal of Molecular Sciences 2014, 15(4):6356-6377. 10.3390/ijms15046356.
10. Baldus S.E., Monig S.P., Hanisch F.G., Zirbes T.K., Flucke U., Oelert S., et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology 2002, 40(5):440-449.
11. Balluff B., Schone C., Hofler H., Walch A. MALDI imaging mass spectrometry for direct tissue analysis: Technological advancements and recent applications. Histochemistry and Cell Biology 2011, 136(3):227-244. 10.1007/s00418-011-0843-x.
12. Balog C.I.A., Stavenhagen K., Fung W.L.J., Koeleman C.A., McDonnell L.A., Verhoeven A., et al. N-glycosylation of colorectal cancer tissues: A liquid chromatography and mass spectrometry-based investigation. Molecular and Cellular Proteomics 2012, 11(9):571-585. 10.1074/mcp.M111.011601.
13. Barkauskas D.A., An H.J., Kronewitter S.R., de Leoz M.L., Chew H.K., de Vere White R.W., et al. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics 2009, 25(2):251-257. 10.1093/bioinformatics/btn610.
14. Barrow H., Guo X., Wandall H.H., Pedersen J.W., Fu B., Zhao Q., et al. Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2011, 17(22):7035-7046. 10.1158/1078-0432.CCR-11-1462.
15. Barrow H., Rhodes J.M., Yu L.G. The role of galectins in colorectal cancer progression. International Journal of Cancer 2011, 129(1):1-8. 10.1002/ijc.25945.
16. Barrow H., Tam B., Duckworth C.A., Rhodes J.M., Yu L.G. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells. PLoS One 2013, 8(3):e59792. 10.1371/journal.pone.0059792.
17. Birklé S., Zeng G., Gao L., Yu R.K., Aubry J. Role of tumor-associated gangliosides in cancer progression. Biochimie 2003, 85(3-4):455-463. 10.1016/s0300-9084(03)00006-3.
18. Bondt A., Rombouts Y., Selman M.H., Hensbergen P.J., Reiding K.R., Hazes J.M., et al. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Molecular & Cellular Proteomics 2014, 13(11):3029-3039. 10.1074/mcp.M114.039537.
19. Bresalier R.S., Mazurek N., Sternberg L.R., Byrd J.C., Yunker C.K., Nangia-Makker P., et al. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology 1998, 115(2):287-296.
20. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1999, 1473(1):67-95. doi:10.1016/S0304-4165(99)00170-1.
21. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: Glycodynamics and functions. EMBO Reports 2006, 7(6):599-604. 10.1038/sj.embor.7400705.
22. Byrd J.C., Bresalier R.S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Reviews 2004, 23(1-2):77-99.
23. Campbell B.J., Finnie I.A., Hounsell E.F., Rhodes J.M. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. The Journal of Clinical Investigation 1995, 95(2):571-576. 10.1172/JCI117700.
24. Cao Q., Zhao X., Zhao Q., Lv X., Li X., Zhao Y., et al. A strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry. Analytical Chemistry 2014, 86(14):6804-6811. 10.1021/ac501154a.
25. Capon C., Wieruszeski J.-M., Lemoine J., Byrd J.C., Leffler H., Kim Y.S. Sulfated Lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin. Journal of Biological Chemistry 1997, 272(51):31957-31968. 10.1074/jbc.272.51.31957.
26. Carlos C.A., Dong H.F., Howard O.M., Oppenheim J.J., Hanisch F.G., Finn O.J. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. Journal of Immunology 2005, 175(3):1628-1635.
27. Cazares L.H., Troyer D., Mendrinos S., Lance R.A., Nyalwidhe J.O., Beydoun H.A., et al. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clinical Cancer Research 2009, 15(17):5541-5551. 10.1158/1078-0432.ccr-08-2892.
28. Cazares L.H., Troyer D.A., Wang B., Drake R.R., John Semmes O. MALDI tissue imaging: From biomarker discovery to clinical applications. Analytical and Bioanalytical Chemistry 2011, 401(1):17-27. 10.1007/s00216-011-5003-6.
29. Chandler K.B., Brnakova Z., Sanda M., Wang S., Stalnaker S.H., Bridger R., et al. Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4. Journal of Proteome Research 2014, 13(7):3314-3329. 10.1021/pr500394z.
30. Chandrasekaran E.V., Xue J., Neelamegham S., Matta K.L. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: A predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydrate Research 2006, 34(8):983-994. doi:10.1016/j.carres.2006.02.017.
31. Chen C.-H., Wang S.-H., Liu C.-H., Wu Y.-L., Wang W.-J., Huang J., et al. β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer. Carcinogenesis 2014, 35(6):1258-1266. 10.1093/carcin/bgu007.
32. Chik J.H.L., Zhou J., Moh E.S.X., Christopherson R., Clarke S.J., Molloy M.P., et al. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: Implications for biomarker studies. Journal of Proteomics 2014, 108(0):146-162. doi:10.1016/j.jprot.2014.05.002.
33. Christiansen M.N., Chik J., Lee L., Anugraham M., Abrahams J.L., Packer N.H. Cell surface protein glycosylation in cancer. Proteomics 2014, 14(4-5):525-546. 10.1002/pmic.201300387.
34. Compton C., Fenoglio-Preiser C.M., Pettigrew N., Fielding L.P. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal working group. Cancer 2000, 88(7):1739-1757.
35. Corfield A.P., Myerscough N., Warren B.F., Durdey P., Paraskeva C., Schauer R. Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconjugate Journal 1999, 16(6):307-317. 10.1023/a:1007026314792.
36. Croci D.O., Cerliani J.P., Dalotto-Moreno T., Mendez-Huergo S.P., Mascanfroni I.D., Dergan-Dylon S., et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 2014, 156(4):744-758. 10.1016/j.cell.2014.01.043.
37. Dai C., Cazares L.H., Wang L., Chu Y., Wang S.L., Troyer D.A., et al. Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen. Chemical Communications 2011, 47(37):10338-10340. 10.1039/C1CC11814E.
38. Dall'Olio F., Malagolini N., di Stefano G., Minni F., Marrano D., Serafini-Cessi F. Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. International Journal of Cancer. Journal International du Cancer 1989, 44(3):434-439.
39. Dall'Olio F., Malagolini N., Trinchera M., Chiricolo M. Mechanisms of cancer-associated glycosylation changes. Frontiers in Bioscience 2012, 17:670-699.
40. Dalziel M., Crispin M., Scanlan C.N., Zitzmann N., Dwek R.A. Emerging principles for the therapeutic exploitation of glycosylation. Science 2014, 343(6166):1235681. 10.1126/science.1235681.
41. Davies R.J., Miller R., Coleman N. Colorectal cancer screening: Prospects for molecular stool analysis. Nature Reviews. Cancer 2005, 5(3):199-209. 10.1038/nrc1569.
42. de Leoz M.L., An H.J., Kronewitter S., Kim J., Beecroft S., Vinall R., et al. Glycomic approach for potential biomarkers on prostate cancer: Profiling of N-linked glycans in human sera and pRNS cell lines. Disease Markers 2008, 25(4-5):243-258.
43. de Leoz M.L.A., Young L.J.T., An H.J., Kronewitter S.R., Kim J., Miyamoto S., et al. High-mannose glycans are elevated during breast cancer progression. Molecular & Cellular Proteomics 2011, 10(1). 10.1074/mcp.M110.002717.
44. Dekker T.J.A., Balluff B.D., Jones E.A., Schöne C.D., Schmitt M., Aubele M., et al. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. Journal of Proteome Research 2014, 13(11).: 4730-4738. 10.1021/pr500253j.
45. Demetriou M., Nabi I.R., Coppolino M., Dedhar S., Dennis J.W. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. The Journal of Cell Biology 1995, 130(2):383-392. 10.1083/jcb.130.2.383.
46. Dennis J.W., Granovsky M., Warren C.E. Glycoprotein glycosylation and cancer progression. Biochimica et Biophysica Acta, General Subjects 1999, 1473(1):21-34. 10.1016/s0304-4165(99)00167-1.
47. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., Kerbel R.S. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236(4801):582-585. 10.1126/science.2953071.
48. Desselle A., Chaumette T., Gaugler M.-H., Cochonneau D., Fleurence J., Dubois N., et al. Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development. PLoS One 2012, 7(11):e45423. 10.1371/journal.pone.0045423.
49. Donczo B., Kerekgyarto J., Szurmai Z., Guttman A. Glycan microarrays: New angles and new strategies. Analyst 2014, 139(11):2650-2657. 10.1039/C3AN02289G.
50. Drake P.M., Cho W., Li B., Prakobphol A., Johansen E., Anderson N.L., et al. Sweetening the pot: Adding glycosylation to the biomarker discovery equation. Clinical Chemistry 2010, 56(2):223-236. 10.1373/clinchem.2009.136333.
51. Durrant L.G., Noble P., Spendlove I. Immunology in the clinic review series; focus on cancer: Glycolipids as targets for tumour immunotherapy. Clinical and Experimental Immunology 2012, 167(2):206-215. 10.1111/j.1365-2249.2011.04516.x.
52. Group, E.C.C.S.G.W. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication. Endoscopy 2013, 45(01):51-59. 10.1055/s-0032-1325997.
53. AJCC cancer staging manual (7th ed) 2010, Springer, New York, NY, ISBN 978-0-387-88440. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
54. Erreni M., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenvironment: Official Journal of the International Cancer Microenvironment Society 2011, 4(2):141-154. 10.1007/s12307-010-0052-5.
55. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61(5):759-767. 10.1016/0092-8674(90)90186-I.
56. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W.W., Comber H., et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer 2013, 49(6):1374-1403. doi:10.1016/j.ejca.2012.12.027.
57. Fernandes B., Sagman U., Auger M., Demetrio M., Dennis J.W. β1-6 Branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Research 1991, 51(2):718-723.
58. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nature Reviews. Immunology 2010, 10(8):554-567. 10.1038/nri2808.
59. Fukasawa T., Asao T., Yamauchi H., Ide M., Tabe Y., Fujii T., et al. Associated expression of alpha2,3sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer. Surgery Today 2013, 43(2):155-162. 10.1007/s00595-012-0141-9.
60. Fung K.Y.C., Nice E., Priebe I., Belobrajdic D., Phatak A., Purins L., et al. Colorectal cancer biomarkers: To be or not to be? Cautionary tales from a road well travelled. World Journal of Gastroenterology 2014, 20(4):888-898.
61. Furukawa K., Hamamura K., Ohkawa Y., Ohmi Y., Furukawa K. Disialyl gangliosides enhance tumor phenotypes with differential modalities. Glycoconjugate Journal 2012, 29(8-9):579-584. 10.1007/s10719-012-9423-0.
62. Gessner P., Riedl S., Quentmaier A., Kemmner W. Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Letters 1993, 75(3):143-149.
63. Giuffre G., Vitarelli E., Tuccari G., Ponz de Leon M., Barresi G. Detection of Tn, sialosyl-Tn and T antigens in hereditary nonpolyposis colorectal cancer. Virchows Archiv: An International Journal of Pathology 1996, 429(6):345-352.
64. Granovsky M., Fata J., Pawling J., Muller W.J., Khokha R., Dennis J.W. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature Medicine 2000, 6(3):306-312.
65. Greenhough A., Smartt H.J., Moore A.E., Roberts H.R., Williams A.C., Paraskeva C., et al. The COX-2/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009, 30(3):377-386. 10.1093/carcin/bgp014.
66. Griesenberg D., Nürnberg R., Bahlo M., Klapdor R. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Anticancer Research 1999, 19(4A):2443-2450.
67. Gruner B.M., Hahne H., Mazur P.K., Trajkovic-Arsic M., Maier S., Esposito I., et al. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. PLoS One 2012, 7(6):e39424. 10.1371/journal.pone.0039424.
68. Gu J., Sato Y., Kariya Y., Isaji T., Taniguchi N., Fukuda T. A mutual regulation between cell-cell adhesion and N-glycosylation: Implication of the bisecting GlcNAc for biological functions. Journal of Proteome Research 2008, 8(2):431-435. 10.1021/pr800674g.
69. Guile G.R., Rudd P.M., Wing D.R., Prime S.B., Dwek R.A. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Analytical Biochemistry 1996, 240(2):210-226. 10.1006/abio.1996.0351.
70. Guo H.B., Lee I., Kamar M., Pierce M. N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. The Journal of Biological Chemistry 2003, 278(52):52412-52424. 10.1074/jbc.M308837200.
71. Gupta G.P., Massague J. Cancer metastasis: Building a framework. Cell 2006, 127(4):679-695. 10.1016/j.cell.2006.11.001.
72. Hakomori S.-I. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Research 1985, 45(6):2405-2414.
73. Hakomori S.-I. Tumor-associated carbohydrate antigens defining tumor malignancy: Basis for development of anti-cancer vaccines. The molecular immunology of complex carbohydrates-2 2001, Vol. 491:369-402. Springer, USA. A. Wu (Ed.).
74. Hakomori S.I., Nudelman E., Levery S.B., Kannagi R. Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. The Journal of Biological Chemistry 1984, 259(7):4672-4680.
75. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013.
76. Hanski C., Drechsler K., Hanisch F.G., Sheehan J., Manske M., Ogorek D., et al. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression. Cancer Research 1993, 53(17):4082-4088.
77. Harvey D.J. Derivatization of carbohydrates for analysis by chromatography; electrophoresis and mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2011, 879(17-18):1196-1225. 10.1016/j.jchromb.2010.11.010.
78. Harvey D.J. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2007-2008. Mass Spectrometry Reviews 2012, 31(2):183-311. 10.1002/mas.20333.
79. Harvey D.J., Dwek R.A., Rudd P.M. Determining the structure of glycan moieties by mass spectrometry. Current protocols in protein science 2006, Vol. 43:12.7.1-12.7.18. Chapter 12, Unit 12 17. 10.1002/0471140864.ps1207s43. J.E. Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.).
80. Häuselmann I., Borsig L. Altered tumor cell glycosylation promotes metastasis. Frontiers in Oncology 2014, 4(28). 10.3389/fonc.2014.00028.
81. Heimburg-Molinaro J., Lum M., Vijay G., Jain M., Almogren A., Rittenhouse-Olson K. Cancer vaccines and carbohydrate epitopes. Vaccine 2011, 29(48):8802-8826. 10.1016/j.vaccine.2011.09.009.
82. Higashi H., Hirabayashi Y., Fukui Y., Naiki M., Matsumoto M., Ueda S., et al. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. Cancer Research 1985, 45(8):3796-3802.
83. Hiltbold E.M., Vlad A.M., Ciborowski P., Watkins S.C., Finn O.J. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. Journal of Immunology 2000, 165(7):3730-3741.
84. Hirakawa M., Takimoto R., Tamura F., Yoshida M., Ono M., Murase K., et al. Fucosylated TGF-[beta] receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. British Journal of Cancer 2014, 110(1):156-163. 10.1038/bjc.2013.699.
85. Holst S., Stavenhagen K., Balog C.I., Koeleman C.A., McDonnell L.M., Mayboroda O.A., et al. Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS). Molecular & Cellular Proteomics: MCP 2013, 12(11):3081-3093. 10.1074/mcp.M113.030387.
86. Honke K., Taniguchi N. Sulfotransferases and sulfated oligosaccharides. Medicinal Research Reviews 2002, 22(6):637-654. 10.1002/med.10020.
87. Hossler P., Khattak S.F., Li Z.J. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 2009, 19(9):936-949. 10.1093/glycob/cwp079.
88. Hua S., Saunders M., Dimapasoc L.M., Jeong S.H., Kim B.J., Kim S.A., et al. Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling. Journal of Proteome Research 2013, 13(2):961-968. 10.1021/pr400987f.
89. Hung J.S., Huang J., Lin Y.C., Huang M.J., Lee P.H., Lai H.S., et al. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. Oncotarget 2014, 5(8):2096-2106.
90. Hutchins J.T., Reading C.L., Giavazzi R., Hoaglund J., Jessup J.M. Distribution of mono-, di-, and tri-O-acetylated sialic acids in normal and neoplastic colon. Cancer Research 1988, 48(2):483-489.
91. Ichikawa T., Nakayama J., Sakura N., Hashimoto T., Fukuda M., Fukuda M.N., et al. Expression of N-acetyllactosamine and β1,4-galactosyltransferase (β4GalT-I) during adenoma-carcinoma sequence in the human colorectum. Journal of Histochemistry and Cytochemistry 1999, 47(12):1593-1601. 10.1177/002215549904701211.
92. Ihara S., Miyoshi E., Ko J.H., Murata K., Nakahara S., Honke K., et al. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. The Journal of Biological Chemistry 2002, 277(19):16960-16967. 10.1074/jbc.M200673200.
93. Inoue M., Takahashi S., Yamashina I., Kaibori M., Okumura T., Kamiyama Y., et al. High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts. Cancer Research 2001, 61(3):950-956.
94. Isaji T., Kariya Y., Xu Q., Fukuda T., Taniguchi N., Gu J. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion. Methods in Enzymology 2010, 480:445-459. 10.1016/S0076-6879(10)80019-9.
95. Ishida H., Togayachi A., Sakai T., Iwai T., Hiruma T., Sato T., et al. A novel β1,3-N-acetylglucosaminyltransferase (β3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Letters 2005, 579(1):71-78. 10.1016/j.febslet.2004.11.037.
96. Itai S., Nishikata J., Yoneda T., Ohmori K., Yamabe H., Arii S., et al. Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract. Cancer 1991, 67(6):1576-1587. 10.1002/1097-0142(19910315)67:6<1576::AID-CNCR2820670620>3.0.CO;2-2.
97. Ito H., Hiraiwa N., Sawada-Kasugai M., Akamatsu S., Tachikawa T., Kasai Y., et al. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. International Journal of Cancer. Journal International du Cancer 1997, 71(4):556-564.
98. Itzkowitz S.H., Bloom E.J., Lau T.S., Kim Y.S. Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut 1992, 33(4):518-523.
99. Itzkowitz S.H., Yuan M., Montgomery C.K., Kjeldsen T., Takahashi H.K., Bigbee W.L., et al. Expression of Tn, Sialosyl-Tn, and T antigens in human colon cancer. Cancer Research 1989, 49(1):197-204.
100. Iwai T., Kudo T., Kawamoto R., Kubota T., Togayachi A., Hiruma T., et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(12):4572-4577. 10.1073/pnas.0407983102.
101. Izawa M., Kumamoto K., Mitsuoka C., Kanamori A., Ohmori K., Ishida H., et al. Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Research 2000, 60(5):1410-1416.
102. Jandus C., Boligan K.F., Chijioke O., Liu H., Dahlhaus M., Demoulins T., et al. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. Journal of Clinical Investigation 2014, 124(4):1810-1820. 10.1172/JCI65899.
103. Jass J.R., Allison L.J., Edgar S.G. Distribution of sialosyl Tn and Tn antigens within normal and malignant colorectal epithelium. The Journal of Pathology 1995, 176(2):143-149. 10.1002/path.1711760207.
104. Jones E.E., Powers T.W., Neely B.A., Cazares L.H., Troyer D.A., Parker A.S., et al. MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics 2014, 14(7-8):924-935. 10.1002/pmic.201300434.
105. Kakugawa Y., Wada T., Yamaguchi K., Yamanami H., Ouchi K., Sato I., et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proceedings of the National Academy of Sciences 2002, 99(16):10718-10723. 10.1073/pnas.152597199.
106. Kalathas D., Theocharis D.A., Bounias D., Kyriakopoulou D., Papageorgakopoulou N., Stavropoulos M.S., et al. Alterations of glycosaminoglycan disaccharide content and composition in colorectal cancer: Structural and expressional studies. Oncology Reports 2009, 22(2):369-375.
107. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconjugate Journal 2003, 20(5):353-364. 10.1023/B:GLYC.0000033631.35357.41.
108. Kannagi R., Izawa M., Koike T., Miyazaki K., Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Science 2004, 95(5):377-384. 10.1111/j.1349-7006.2004.tb03219.x.
109. Kannagi R., Sakuma K., Miyazaki K., Lim K.T., Yusa A., Yin J., et al. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers. Cancer Science 2010, 101(3):586-593. 10.1111/j.1349-7006.2009.01455.x.
110. Kannagi R., Yin J., Miyazaki K., Izawa M. Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochimica et Biophysica Acta (BBA) - General Subjects 2008, 1780(3):525-531. doi:10.1016/j.bbagen.2007.10.007.
111. Kawakami Y., Kawakami K., Steelant W.F.A., Ono M., Baek R.C., Handa K., et al. Tetraspanin CD9 is a "proteolipid", and its interaction with α3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent Cell motility. Journal of Biological Chemistry 2002, 277(37):34349-34358. 10.1074/jbc.M200771200.
112. Kemik O., Kemik A.S., Sumer A., Begenik H., Purisa S., Tuzun S. Human neutrophil peptides 1, 2 and 3 (HNP 1-3): Elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis. Human & Experimental Toxicology 2013, 32(2):167-171. 10.1177/0960327111412802.
113. Khare V., Lang M., Dammann K., Campregher C., Lyakhovich A., Gasche C. Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells. Biochemical Pharmacology 2014, 87(2):312-320. doi:10.1016/j.bcp.2013.10.021.
114. Kim Y.-S., Hwang S.Y., Kang H.-Y., Sohn H., Oh S., Kim J.-Y., et al. Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Molecular & Cellular Proteomics 2008, 7(1):1-14. 10.1074/mcp.M700084-MCP200.
115. Kim S.W., Park K.C., Jeon S.M., Ohn T.B., Kim T.I., Kim W.H., et al. Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer. Cellular Oncology 2013, 36(2):169-178. 10.1007/s13402-013-0124-x.
116. Kirmiz C., Li B., An H.J., Clowers B.H., Chew H.K., Lam K.S., et al. A serum glycomics approach to breast cancer biomarkers. Molecular & Cellular Proteomics: MCP 2007, 6(1):43-55. 10.1074/mcp.M600171-MCP200.
117. Klee E.W., Bondar O.P., Goodmanson M.K., Trushin S.A., Singh R.J., Anderson N.L., et al. Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immune-extracted PSA provide a potential strategy for harmonizing immunoassay differences. American Journal of Clinical Pathology 2014, 141(4):527-533. 10.1309/AJCP8PEL0YXAHDVK.
118. Kohla G., Stockfleth E., Schauer R. Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin. Neurochemical Research 2002, 27(7-8):583-592. 10.1023/a%3a1020211714104.
119. Koike T., Kimura N., Miyazaki K., Yabuta T., Kumamoto K., Takenoshita S., et al. Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(21):8132-8137. 10.1073/pnas.0402088101.
120. Konno A., Hoshino Y., Terashima S., Motoki R., Kawaguchi T. Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clinical & Experimental Metastasis 2002, 19(1):61-70.
121. Kottler R., Mank M., Hennig R., Müller-Werner B., Stahl B., Reichl U., et al. Development of a high-throughput glycoanalysis method for the characterization of oligosaccharides in human milk utilizing multiplexed capillary gel electrophoresis with laser-induced fluorescence detection. Electrophoresis 2013, 34(16):2323-2336. 10.1002/elps.201300016.
122. Kovbasnjuk O., Mourtazina R., Baibakov B., Wang T., Elowsky C., Choti M.I.A., et al. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(52):19087-19092. 10.1073/pnas.0506474102.
123. Kudo T., Ikehara Y., Togayachi A., Morozumi K., Watanabe M., Nakamura M., et al. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Laboratory Investigation; A Journal of Technical Methods and Pathology 1998, 78(7):797-811.
124. Kuzmanov U., Kosanam H., Diamandis E.P. The sweet and sour of serological glycoprotein tumor biomarker quantification. BMC Medicine 2013, 11:31. 10.1186/1741-7015-11-31.
125. Labianca R., Nordlinger B., Beretta G.D., Mosconi S., Mandalà M., Cervantes A. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2013, 24(Suppl. 6):vi64-vi72. 10.1093/annonc/mdt354.
126. Lau K.S., Partridge E.A., Grigorian A., Silvescu C.I., Reinhold V.N., Demetriou M., et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007, 129(1):123-134. [pii]10.1016/j.cell.2007.01.049. http://dx.doi.org/S0092-8674(07)00315-7.
127. Lee J.H. Clinical usefulness of serum CYFRA 21-1 in patients with colorectal cancer. Nuclear Medicine and Molecular Imaging 2013, 47(3):181-187. 10.1007/s13139-013-0218-4.
128. Lee M., Lee H.J., Bae S., Lee Y.S. Protein sialylation by sialyltransferase involves radiation resistance. Molecular Cancer Research 2008, 6(8):1316-1325. 10.1158/1541-7786.MCR-07-2209.
129. Lee M., Lee H.J., Seo W.D., Park K.H., Lee Y.S. Sialylation of integrin beta1 is involved in radiation-induced adhesion and migration in human colon cancer cells. International Journal of Radiation Oncology, Biology, Physics 2010, 76(5):1528-1536. 10.1016/j.ijrobp.2009.11.022.
130. Lee M., Park J.J., Ko Y.G., Lee Y.S. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits Golgi-anchored ST6Gal I-mediated sialylation of integrin beta1 and migration in colon cancer cells. Radiation Oncology 2012, 7:47. 10.1186/1748-717X-7-47.
131. Lee M., Park J.J., Lee Y.S. Adhesion of ST6Gal I-mediated human colon cancer cells to fibronectin contributes to cell survival by integrin beta1-mediated paxillin and AKT activation. Oncology Reports 2010, 23(3):757-761.
132. Legendre H., Decaestecker C., Nagy N., Hendlisz A., Schuring M.P., Salmon I., et al. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Modern Pathology 2003, 16(5):491-504. 10.1097/01.MP.0000068235.45178.C1.
133. Levin B., Lieberman D.A., McFarland B., Smith R.A., Brooks D., Andrews K.S., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians 2008, 58(3):130-160. 10.3322/CA.2007.0018.
134. Lin S., Kemmner W., Grigull S., Schlag P.M. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Experimental Cell Research 2002, 276(1):101-110. 10.1006/excr.2002.5521.
135. Lingwood C.A. Verotoxin/globotriaosyl ceramide recognition: Angiopathy, angiogenesis and antineoplasia. Bioscience Reports 1999, 19(5):345-354. 10.1023/a:1020299819637.
136. Liu L., Yan B., Huang J., Gu Q., Wang L., Fang M., et al. The identification and characterization of novel N-glycan-based biomarkers in gastric cancer. PLoS One 2013, 8(10):e77821. 10.1371/journal.pone.0077821.
137. Liu M., Zhang Y., Chen Y., Yan G., Shen C., Cao J., et al. Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis. Journal of Proteome Research 2014, 13(6):3121-3129. 10.1021/pr500238v.
138. Lonardi E., Balog C.I., Deelder A.M., Wuhrer M. Natural glycan microarrays. Expert Review of Proteomics 2010, 7(5):761-774. 10.1586/epr.10.41.
139. Lonardi E., Deelder A.M., Wuhrer M., Balog C.A. Microarray technology using glycans extracted from natural sources for serum antibody fluorescent detection. Carbohydrate microarrays 2012, Vol. 808:285-302. Humana Press. Y. Chevolot (Ed.).
140. Magnani J.L. The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Archives of Biochemistry and Biophysics 2004, 426(2):122-131. 10.1016/j.abb.2004.04.008.
141. Mann B., Klussmann E., Vandamme-Feldhaus V., Iwersen M., Hanski M.-L., Riecken E.-O., et al. Low O-acetylation of sialyl-LEx contributes to its overexpression in colon carcinoma metastases. International Journal of Cancer 1997, 72(2):258-264. 10.1002/(sici)1097-0215(19970717)72:2<258::aid-ijc10>3.0.co;2-c.
142. Mare L., Caretti A., Albertini R., Trinchera M. CA19.9 antigen circulating in the serum of colon cancer patients: Where is it from?. International Journal of Biochemistry & Cell Biology 2013, 45(4):792-797. 10.1016/j.biocel.2013.01.004.
143. Markowska A.I., Jefferies K.C., Panjwani N. Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. The Journal of Biological Chemistry 2011, 286(34):29913-29921. 10.1074/jbc.M111.226423.
144. Mazurek N., Byrd J.C., Sun Y., Hafley M., Ramirez K., Burks J., et al. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death and Differentiation 2012, 19(3):523-533. 10.1038/cdd.2011.123.
145. McElvania TeKippe E., Burnham C.A. Evaluation of the Bruker Biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2014, 33(12):2163-2171. 10.1007/s10096-014-2183-y.
146. Mechref Y., Hu Y., Garcia A., Hussein A. Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis 2012, 33(12):1755-1767. 10.1002/elps.201100715.
147. Mechref Y., Kang P., Novotny M.V. Differentiating structural isomers of sialylated glycans by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight tandem mass spectrometry. Rapid Communications in Mass Spectrometry: RCM 2006, 20(8):1381-1389. 10.1002/rcm.2445.
148. Mejías-Luque R., López-Ferrer A., Garrido M., Fabra À., De Bolós C. Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1. Cancer Science 2007, 98(7):1000-1005. 10.1111/j.1349-7006.2007.00484.x.
149. Minerva L., Ceulemans A., Baggerman G., Arckens L. MALDI MS imaging as a tool for biomarker discovery: Methodological challenges in a clinical setting. Proteomics. Clinical Applications 2012, 6(11-12):581-595. 10.1002/prca.201200033.
150. Misonou Y., Shida K., Korekane H., Seki Y., Noura S., Ohue M., et al. Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: Elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. Journal of Proteome Research 2009, 8(6):2990-3005. 10.1021/pr900092r.
151. Miyazaki K., Ohmori K., Izawa M., Koike T., Kumamoto K., Furukawa K., et al. Loss of Disialyl Lewis a, the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis a expression on human colon cancers. Cancer Research 2004, 64(13):4498-4505. 10.1158/0008-5472.can-03-3614.
152. Miyazaki K., Sakuma K., Kawamura Y.I., Izawa M., Ohmori K., Mitsuki M., et al. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9. Journal of Immunology 2012, 188(9):4690-4700. 10.4049/jimmunol.1100605.
153. Miyoshi E., Moriwaki K., Nakagawa T. Biological function of fucosylation in cancer biology. Journal of Biochemistry 2008, 143(6):725-729. 10.1093/jb/mvn011.
154. Morelle W., Michalski J.-C. Analysis of protein glycosylation by mass spectrometry. Nature Protocols 2007, 2(7):1585-1602.
155. Morichika H., Hamanaka Y., Tai T., Ishizuka I. Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer 1996, 78(1):43-47. 10.1002/(SICI)1097-0142(19960701)78:1<43::AID-CNCR8>3.0.CO;2-I.
156. Moriwaki K. Fucosylation and gastrointestinal cancer. World Journal of Hepatology 2010, 2(4):151. 10.4254/wjh.v2.i4.151.
157. Moriwaki K., Noda K., Furukawa Y., Ohshima K., Uchiyama A., Nakagawa T., et al. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology 2009, 137(1):188-198. 10.1053/j.gastro.2009.04.002.
158. Moriwaki K., Shinzaki S., Miyoshi E. GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation. The Journal of Biological Chemistry 2011, 286(50):43123-43133. 10.1074/jbc.M111.262741.
159. Muinelo-Romay L., Gil-Martin E., Fernandez-Briera A. Alpha(1,2)fucosylation in human colorectal carcinoma. Oncology Letters 2010, 1(2):361-366. 10.3892/ol_00000064.
160. Muinelo-Romay L., Vázquez-Martín C., Villar-Portela S., Cuevas E., Gil-Martín E., Fernández-Briera A. Expression and enzyme activity of α(1,6)fucosyltransferase in human colorectal cancer. International Journal of Cancer 2008, 123(3):641-646. 10.1002/ijc.23521.
161. Murata K., Miyoshi E., Ihara S., Noura S., Kameyama M., Ishikawa O., et al. Attachment of human colon cancer cells to vascular endothelium is enhanced by N-acetylglucosaminyltransferase V. Oncology 2004, 66(6):492-501. 10.1159/000079504.
162. Murata K., Miyoshi E., Kameyama M., Ishikawa O., Kabuto T., Sasaki Y., et al. Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clinical Cancer Research 2000, 6(5):1772-1777.
163. Nagy N., Bronckart Y., Camby I., Legendre H., Lahm H., Kaltner H., et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 2002, 50(3):392-401.
164. Nakagoe T., Fukushima K., Nanashima A., Sawai T., Tsuji T., Jibiki M., et al. Expression of Lewis a, sialyl Lewis a, Lewis x, sialyl Lewis x, antigens as prognostic factors in patients with colorectal cancer. Canadian Journal of Gastroenterology & Hepatology 2000, 14(9):753-760.
165. Nakagoe T., Sawai T., Tsuji T., Jibiki M., Nanashima A., Yamaguchi H., et al. Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: Multivariate analysis of predictive factors for serum antigen levels. Journal of Gastroenterology 2001, 36(3):166-172.
166. Nakayama K., Moriwaki K., Imai T., Shinzaki S., Kamada Y., Murata K., et al. Mutation of GDP-mannose-4,6-dehydratase in colorectal cancer metastasis. PLoS One 2013, 8(7):e70298. 10.1371/journal.pone.0070298.
167. Nakayama T., Watanabe M., Katsumata T., Teramoto T., Kitajima M. Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995, 75(8):2051-2056.
168. Napoletano C., Rughetti A., Agervig Tarp M.P., Coleman J., Bennett E.P., Picco G., et al. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Research 2007, 67(17):8358-8367. 10.1158/0008-5472.CAN-07-1035.
169. Ni J., Jiang Z., Shen L., Gao L., Yu M., Xu X., et al. beta3GnT8 regulates the metastatic potential of colorectal carcinoma cells by altering the glycosylation of CD147. Oncology Reports 2014, 31(4):1795-1801. 10.3892/or.2014.3042.
170. Nishihara R., Wu K., Lochhead P., Morikawa T., Liao X., Qian Z.R., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. The New England Journal of Medicine 2013, 369(12):1095-1105. 10.1056/NEJMoa1301969.
171. Nonaka M., Imaeda H., Matsumoto S., Yong Ma B., Kawasaki N., Mekata E., et al. Mannan-binding protein, a C-type serum lectin, recognizes primary colorectal carcinomas through tumor-associated Lewis glycans. Journal of Immunology 2014, 192(3):1294-1301. 10.4049/jimmunol.1203023.
172. Nonaka M., Ma B.Y., Murai R., Nakamura N., Baba M., Kawasaki N., et al. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. Journal of Immunology 2008, 180(5):3347-3356.
173. Nudelman E.D., Levery S.B., Stroud M.R., Salyan M.E., Abe K., Hakomori S. A novel tumor-associated, developmentally regulated glycolipid antigen defined by monoclonal antibody ACFH-18. Journal of Biological Chemistry 1988, 263(27):13942-13951.
174. Ogata S., Maimonis P.J., Itzkowitz S.H. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural-killer-cell cytotoxicity. Cancer Research 1992, 52(17):4741-4746.
175. Ohtsubo K., Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126(5):855-867. 10.1016/j.cell.2006.08.019.
176. Ono M., Handa K., Sonnino S., Withers D.A., Nagai H., Hakomori S. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: Coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 2001, 40(21):6414-6421.
177. Osumi D., Takahashi M., Miyoshi E., Yokoe S., Lee S.H., Noda K., et al. Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Science 2009, 100(5):888-895. 10.1111/j.1349-7006.2009.01125.x.
178. Paprocka M., Dus D., Mitterrand M., Lamerant-Fayel N., Kieda C. Flow cytometric assay for quantitative and qualitative evaluation of adhesive interactions of tumor cells with endothelial cells. Microvascular Research 2008, 76(2):134-138. 10.1016/j.mvr.2008.03.004.
179. Park J.J., Lee M. Increasing the alpha 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut and Liver 2013, 7(6):629-641. 10.5009/gnl.2013.7.6.629.
180. Park J.J., Yi J.Y., Jin Y.B., Lee Y.J., Lee J.S., Lee Y.S., et al. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochemical Pharmacology 2012, 83(7):849-857. 10.1016/j.bcp.2012.01.007.
181. Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R., Graham M.E., et al. Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity. Journal of Proteome Research 2013, 12(12):5791-5800. 10.1021/pr400783j.
182. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306(5693):120-124. http://dx.doi.org/10.1126/science.1102109306/5693/120 [pii].
183. Paschos K.A., Canovas D., Bird N.C. The engagement of selectins and their ligands in colorectal cancer liver metastases. Journal of Cellular and Molecular Medicine 2010, 14(1-2):165-174. 10.1111/j.1582-4934.2009.00852.x.
184. Patsos G., Hebbe-Viton V., Robbe-Masselot C., Masselot D., San Martin R., Greenwood R., et al. O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. Glycobiology 2009, 19(4):382-398. 10.1093/glycob/cwn149.
185. Peracaula R., Barrabes S., Sarrats A., Rudd P.M., de Llorens R. Altered glycosylation in tumours focused to cancer diagnosis. Disease Markers 2008, 25(4-5):207-218.
186. Pérez-Garay M., Arteta B., Llop E., Cobler L., Pagès L., Ortiz R., et al. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. The International Journal of Biochemistry & Cell Biology 2013, 45(8):1748-1757. doi:10.1016/j.biocel.2013.05.015.
187. Phueaouan T., Chaiyawat P., Netsirisawan P., Chokchaichamnankit D., Punyarit P., Srisomsap C., et al. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncology Reports 2013, 30(6):2929-2936. 10.3892/or.2013.2794.
188. Plomp R., Hensbergen P.J., Rombouts Y., Zauner G., Dragan I., Koeleman C.A., et al. Site-specific N-glycosylation analysis of human immunoglobuline. Journal of Proteome Research 2014, 13(2):536-546. 10.1021/pr400714w.
189. Powers T.W., Jones E.E., Betesh L.R., Romano P.R., Gao P., Copland J.A., et al. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Analytical Chemistry 2013, 85(20):9799-9806. 10.1021/ac402108x.
190. Qiu Y., Patwa T.H., Xu L., Shedden K., Misek D.E., Tuck M., et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. Journal of Proteome Research 2008, 7(4):1693-1703. 10.1021/pr700706s.
191. Ranjan A., Kalraiya R.D. alpha2,6 sialylation associated with increased beta 1,6-branched N-oligosaccharides influences cellular adhesion and invasion. Journal of Biosciences 2013, 38(5):867-876.
192. Ravindranath M.H., Muthugounder S., Presser N. Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient. Melanoma Research 2008, 18(1):47-55.
193. Razavi M., Frick L.E., LaMarr W.A., Pope M.E., Miller C.A., Anderson N.L., et al. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. Journal of Proteome Research 2012, 11(12):5642-5649. 10.1021/pr300652v.
194. Recchi M.A., Hebbar M., Hornez L., Harduin-Lepers A., Peyrat J.P., Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Research 1998, 58(18):4066-4070.
195. Reiding K.R., Blank D., Kuijper D.M., Deelder A.M., Wuhrer M. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal Chem. 2014, 86(12):5784-5793. 10.1021/ac500335t.
196. Reis C.A., Campos D., Osorio H., Santos L.L. Glycopeptide microarray for autoantibody detection in cancer. Expert Review of Proteomics 2011, 8(4):435-437. 10.1586/EPR.11.30.
197. Reis C.A., David L., Seixas M., Burchell J., Sobrinho-Simoes M. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. International Journal of Cancer. Journal International du Cancer 1998, 79(4):402-410.
198. Reis C.A., Osorio H., Silva L., Gomes C., David L. Alterations in glycosylation as biomarkers for cancer detection. Journal of Clinical Pathology 2010, 63(4):322-329. 10.1136/jcp.2009.071035.
199. Reiter W., Stieber P., Reuter C., Nagel D., Lau-Werner U., Lamerz R. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Research 2000, 20(6D):5195-5198.
200. Rho J.H., Mead J.R., Wright W.S., Brenner D.E., Stave J.W., Gildersleeve J.C., et al. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays. Journal of Proteomics 2014, 96:291-299. 10.1016/j.jprot.2013.10.030.
201. Robbe-Masselot C., Herrmann A., Maes E., Carlstedt I., Michalski J.C., Capon C. Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: A potential marker of malignant transformation in colon. Journal of Proteome Research 2009, 8(2):702-711. 10.1021/pr800740j.
202. Rogeberg M., Malerod H., Roberg-Larsen H., Aass C., Wilson S.R. On-line solid phase extraction-liquid chromatography, with emphasis on modern bioanalysis and miniaturized systems. Journal of Pharmaceutical and Biomedical Analysis 2014, 87:120-129. 10.1016/j.jpba.2013.05.006.
203. Rosivatz E., Becker I., Bamba M., Schott C., Diebold J., Mayr D., et al. Neoexpression of N-cadherin in E-cadherin positive colon cancers. International Journal of Cancer 2004, 111(5):711-719. 10.1002/ijc.20317.
204. Royle L., Campbell M.P., Radcliffe C.M., White D.M., Harvey D.J., Abrahams J.L., et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Analytical Biochemistry 2008, 376(1):1-12. 10.1016/j.ab.2007.12.012.
205. Ruhaak L.R., Zauner G., Huhn C., Bruggink C., Deelder A.M., Wuhrer M. Glycan labeling strategies and their use in identification and quantification. Analytical and Bioanalytical Chemistry 2010, 397(8):3457-3481. 10.1007/s00216-010-3532-z.
206. Sadahiro S., Suzuki T., Ishikawa K., Nakamura T., Tanaka Y., Masuda T., et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepato-Gastroenterology 2003, 50(53):1362-1366.
207. Saeland E., Belo A.I., Mongera S., van Die I., Meijer G.A., van Kooyk Y. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients. International Journal of Cancer. Journal International du Cancer 2012, 131(1):117-128. 10.1002/ijc.26354.
208. Saeland E., van Kooyk Y. Highly glycosylated tumour antigens: Interactions with the immune system. Biochemical Society Transactions 2011, 39(1):388-392. 10.1042/BST0390388.
209. Saeland E., van Vliet S.J., Backstrom M., van den Berg V.C., Geijtenbeek T.B., Meijer G.A., et al. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunology, Immunotherapy 2007, 56(8):1225-1236. 10.1007/s00262-006-0274-z.
210. Sakamoto J., Furukawa K., Cordon-Cardo C., Yin B.W., Rettig W.J., Oettgen H.F., et al. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Research 1986, 46(3):1553-1561.
211. Samraj A.N., Laubli H., Varki N., Varki A. Involvement of a non-human sialic acid in human cancer. Frontiers in Oncology 2014, 4:33. 10.3389/fonc.2014.00033.
212. Satelli A., Rao P.S., Thirumala S., Rao U.S. Galectin-4 functions as a tumor suppressor of human colorectal cancer. International Journal of Cancer 2011, 129(4):799-809. 10.1002/ijc.25750.
213. Satomaa T., Heiskanen A., Leonardsson I., Angstrom J., Olonen A., Blomqvist M., et al. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Research 2009, 69(14):5811-5819. 10.1158/0008-5472.CAN-08-0289.
214. Sawada M., Moriya S., Saito S., Shineha R., Satomi S., Yamori T., et al. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. International Journal of Cancer 2002, 97(2):180-185. 10.1002/ijc.1598.
215. Schauer R., Srinivasan G.V., Wipfler D., Kniep B., Schwartz-Albiez R. O-acetylated sialic acids and their role in immune defense. The molecular immunology of complex carbohydrates-3 2011, Vol. 705:525-548. Springer, USA. A.M. Wu (Ed.).
216. Schmoll H.J., Van Cutsem E., Stein A., Valentini V., Glimelius B., Haustermans K., et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Annals of Oncology 2012, 23(10):2479-2516. 10.1093/annonc/mds236.
217. Schneider F., Kemmner W., Haensch W., Franke G., Gretschel S., Karsten U., et al. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Research 2001, 61(11):4605-4611.
218. Seales E.C., Jurado G.A., Brunson B.A., Wakefield J.K., Frost A.R., Bellis S.L. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Research 2005, 65(11):4645-4652. 10.1158/0008-5472.CAN-04-3117.
219. Selman M.H., Hemayatkar M., Deelder A.M., Wuhrer M. Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. Analytical Chemistry 2011, 83(7):2492-2499. 10.1021/ac1027116.
220. Sethi M.K., Thaysen-Andersen M., Smith J.T., Baker M.S., Packer N.H., Hancock W.S., et al. Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. Journal of Proteome Research 2013, 13(1):277-288. 10.1021/pr400861m.
221. Shatnyeva O.M., Kubarenko A.V., Weber C.E., Pappa A., Schwartz-Albiez R., Weber A.N., et al. Modulation of the CD95-induced apoptosis: The role of CD95 N-glycosylation. PLoS One 2011, 6(5):e19927. 10.1371/journal.pone.0019927.
222. Shen Y., Kohla G., Lrhorfi A.L., Sipos B., Kalthoff H., Gerwig G.J., et al. O-acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma. European Journal of Biochemistry 2004, 271(2):281-290. 10.1046/j.1432-1033.2003.03927.x.
223. Shida K., Misonou Y., Korekane H., Seki Y., Noura S., Ohue M., et al. Unusual accumulation of sulfated glycosphingolipids in colon cancer cells. Glycobiology 2009, 19(9):1018-1033. 10.1093/glycob/cwp083.
224. Shimodaira K., Nakayama J., Nakamura N., Hasebe O., Katsuyama T., Fukuda M. Carcinoma-associated expression of core 2 β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression. Cancer Research 1997, 57(23):5201-5206.
225. Shiozaki K., Yamaguchi K., Takahashi K., Moriya S., Miyagi T. Regulation of sialyl Lewis antigen expression in colon cancer cells by sialidase NEU4. The Journal of Biological Chemistry 2011, 286(24):21052-21061. 10.1074/jbc.M111.231191.
226. Shiratori Y., Nakata R., Okano K., Komatsu Y., Shiina S., Kawase T., et al. Inhibition of hepatic metastasis of colon carcinoma by asialo GM1-positive cells in the liver. Hepatology 1992, 16(2):469-478.
227. Singh S.K., Streng-Ouwehand I., Litjens M., Kalay H., Saeland E., van Kooyk Y. Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. International Journal of Cancer 2011, 128(6):1371-1383. 10.1002/ijc.25458.
228. Song Y., Aglipay J.A., Bernstein J.D., Goswami S., Stanley P. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression. Cancer Research 2010, 70(8):3361-3371. 10.1158/0008-5472.can-09-2719.
229. St Hill C.A., Baharo-Hassan D., Farooqui M. C2-O-sLe(X) glycoproteins are E-selectin ligands that regulate Invasion of human colon and hepatic carcinoma cells. PLoS One 2011, 6(1). http://dx.doi.org/ARTN e16281. 10.1371/journal.pone.0016281.
230. St Hill C.A., Farooqui M., Mitcheltree G., Gulbahce H.E., Jessurun J., Cao Q., et al. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer 2009, 9:79. 10.1186/1471-2407-9-79.
231. Stefatic D., Riederer M., Balic M., Dandachi N., Stanzer S., Janesch B., et al. Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum. Bosnian Journal of Basic Medical Sciences/Udruzenje basicnih mediciniskih znanosti=Association of Basic Medical Sciences 2008, 8(3):245-250.
232. Stumpo K.A., Reinhold V.N. The N-glycome of human plasma. Journal of Proteome Research 2010, 9(9):4823-4830. 10.1021/pr100528k.
233. Swindall A.F., Bellis S.L. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. The Journal of Biological Chemistry 2011, 286(26):22982-22990. 10.1074/jbc.M110.211375.
234. Takamiya R., Ohtsubo K., Takamatsu S., Taniguchi N., Angata T. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-beta secretion from monocytes/macrophages through the DAP12-Syk pathway. Glycobiology 2013, 23(2):178-187. 10.1093/glycob/cws139.
235. Takeda Y., Shinzaki S., Okudo K., Moriwaki K., Murata K., Miyoshi E. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer 2012, 118(12):3036-3043. 10.1002/cncr.26490.
236. Tanida S., Akita K., Ishida A., Mori Y., Toda M., Inoue M., et al. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of beta-catenin and subsequent cell growth. The Journal of Biological Chemistry 2013, 288(44):31842-31852. 10.1074/jbc.M113.471318.
237. Taniuchi F., Higai K., Tanaka T., Azuma Y., Matsumoto K. Transcriptional regulation of fucosyltransferase 1 gene expression in colon cancer cells. TheScientificWorldJournal 2013, 2013:105464. 10.1155/2013/105464.
238. Taylor R.E., Gregg C.J., Padler-Karavani V., Ghaderi D., Yu H., Huang S., et al. Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. The Journal of Experimental Medicine 2010, 207(8):1637-1646. 10.1084/jem.20100575.
239. Terraneo L., Avagliano L., Caretti A., Bianciardi P., Tosi D., Bulfamante G.P., et al. Expression of carbohydrate-antigen sialyl-Lewis a on colon cancer cells promotes xenograft growth and angiogenesis in nude mice. The International Journal of Biochemistry & Cell Biology 2013, 45(12):2796-2800. 10.1016/j.biocel.2013.10.003.
240. Thaysen-Andersen M., Packer N.H. Advances in LC-MS/MS-based glycoproteomics: Getting closer to system-wide site-specific mapping of the N- and O-glycoproteome. Biochimica et Biophysica Acta 2014, 1844(9):1437-1452. 10.1016/j.bbapap.2014.05.002.
241. Thirunavukarasu P., Sukumar S., Sathaiah M., Mahan M., Pragatheeshwar K.D., Pingpank J.F., et al. C-stage in colon cancer: Implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. Journal of the National Cancer Institute 2011, 103(8):689-697. 10.1093/jnci/djr078.
242. Tian Y., Zhang H. Characterization of disease-associated N-linked glycoproteins. Proteomics 2013, 13(3-4):504-511. 10.1002/pmic.201200333.
243. Tousi F., Bones J., Hancock W.S., Hincapie M. Differential chemical derivatization integrated with chromatographic separation for analysis of isomeric sialylated N-glycans: A nano-hydrophilic interaction liquid chromatography-MS platform. Analytical Chemistry 2013, 85(17):8421-8428. 10.1021/ac4018007.
244. Trinchera M., Malagolini N., Chiricolo M., Santini D., Minni F., Caretti A., et al. The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. The International Journal of Biochemistry & Cell Biology 2011, 43(1):130-139. doi:10.1016/j.biocel.2010.10.004.
245. Tsang A.H., Cheng K.H., Wong A.S., Ng S.S., Ma B.B., Chan C.M., et al. Current and future molecular diagnostics in colorectal cancer and colorectal adenoma. World Journal of Gastroenterology: WJG 2014, 20(14):3847-3857. 10.3748/wjg.v20.i14.3847.
246. Uemura T., Shiozaki K., Yamaguchi K., Miyazaki S., Satomi S., Kato K., et al. Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin [beta]4. Oncogene 2009, 28(9):1218-1229. http://www.nature.com/onc/journal/v28/n9/suppinfo/onc2008471s1.html, 10.1038/onc.2008.471.
247. Varki A. Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution. American Journal of Physical Anthropology 2001, 33(Suppl. 33):54-69.
248. Varki A. Sialic acids in human health and disease. Trends in Molecular Medicine 2008, 14(8):351-360. 10.1016/j.molmed.2008.06.002.
249. Varki A., Kannagi R., Toole B.P. Glycosylation changes in cancer. Essentials of glycobiology 2009, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2nd ed.
250. Vavasseur F., Dole K., Yang J., Matta K.L., Myerscough N., Corfield A., et al. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. European Journal of Biochemistry/FEBS 1994, 222(2):415-424.
251. Vercoutter-Edouart A.S., Slomianny M.C., Dekeyzer-Beseme O., Haeuw J.F., Michalski J.C. Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells. Proteomics 2008, 8(16):3236-3256. 10.1002/pmic.200800151.
252. Wagner K.W., Punnoose E.A., Januario T., Lawrence D.A., Pitti R.M., Lancaster K., et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nature Medicine 2007, 13(9):1070-1077. 10.1038/nm1627.
253. Wang P.H., Lee W.L., Lee Y.R., Juang C.M., Chen Y.J., Chao H.T., et al. Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma. Gynecologic Oncology 2003, 89(3):395-401.
254. Wang C., Wu Z., Yuan J., Wang B., Zhang P., Zhang Y., et al. Simplified quantitative glycomics using the stable isotope label Girard's reagent p by electrospray ionization mass spectrometry. Journal of Proteome Research 2014, 13(2):372-384. 10.1021/pr4010647.
255. Waszkiewicz N., Zalewska-Szajda B., Szajda S.D., Kepka A., Waszkiewicz M., Roszkowska-Jakimiec W., et al. Lysosomal exoglycosidases and cathepsin D in colon adenocarcinoma. Polskie Archiwum Medycyny Wewnętrznej 2012, 122(11):551-556.
256. Weston B.W., Hiller K.M., Mayben J.P., Manousos G.A., Bendt K.M., Liu R., et al. Expression of human α(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Research 1999, 59(9):2127-2135.
257. Wheeler S.F., Domann P., Harvey D.J. Derivatization of sialic acids for stabilization in matrix-assisted laser desorption/ionization mass spectrometry and concomitant differentiation of α(2→3)- and α(2→6)-isomers. Rapid Communications in Mass Spectrometry 2009, 23(2):303-312. 10.1002/rcm.3867.
258. Wilczek E., Rzepko R., Nowis D., Legat M., Golab J., Glab M., et al. The possible role of factor H in colon cancer resistance to complement attack. International Journal of Cancer 2008, 122(9):2030-2037. 10.1002/ijc.23238.
259. Williams T.I., Saggese D.A., Muddiman D.C. Studying O-linked protein glycosylations in human plasma. Journal of Proteome Research 2008, 7(6):2562-2568. 10.1021/pr800066e.
260. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003, 124(2):544-560. 10.1053/gast.2003.50044.
261. Wolpin B.M., Mayer R.J. Systemic treatment of colorectal cancer. Gastroenterology 2008, 134(5):1296-1310. e1291.
262. Wuhrer M. Glycomics using mass spectrometry. Glycoconjugate Journal 2013, 30(1):11-22. 10.1007/s10719-012-9376-3.
263. Wuhrer M., Deelder M., Hokke C.H. Protein glycosylation analysis by liquid chromatography-mass spectrometry. Journal of Chromatography B 2005, 825(2):124-133. doi:10.1016/j.jchromb.2005.01.030.
264. Wuhrer M., Catalina M.I., Deelder A.M., Hokke C.H. Glycoproteomics based on tandem mass spectrometry of glycopeptides. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Science 2007, 849(1-2):115-128. 10.1016/j.jchromb.2006.09.041.
265. Xu Q., Isaji T., Lu Y., Gu W., Kondo M., Fukuda T., et al. Roles of N-acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by transforming growth factor β1 (TGF-β1) in epithelial cell lines. Journal of Biological Chemistry 2012, 287(20):16563-16574. 10.1074/jbc.M111.262154.
266. Yang J.M., Byrd J.C., Siddiki B.B., Chung Y.S., Okuno M., Sowa M., et al. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 1994, 4(6):873-884.
267. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(19):8754-8758.
268. Yu L.G., Andrews N., Zhao Q., McKean D., Williams J.F., Connor L.J., et al. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. The Journal of Biological Chemistry 2007, 282(1):773-781. 10.1074/jbc.M606862200.
269. Yue T., Goldstein I.J., Hollingsworth M.A., Kaul K., Brand R.E., Haab B.B. The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Molecular and Cellular Proteomics 2009, 8(7):1697-1707.
270. Zaia J. On-line separations combined with MS for analysis of glycosaminoglycans. Mass Spectrometry Reviews 2009, 28(2):254-272. 10.1002/mas.20200.
271. Zaia J. Mass spectrometry and glycomics. Omics: A Journal of Integrative Biology 2010, 14(4):401-418. 10.1089/omi.2009.0146.
272. Zaia Povegliano L., Oshima C.T., de Oliveira Lima F., Andrade Scherholz P.L., Manoukian Forones N. Immunoexpression of galectin-3 in colorectal cancer and its relationship with survival. Journal of Gastrointestinal Cancer 2011, 42(4):217-221. 10.1007/s12029-010-9189-1.
273. Zauner G., Deelder A.M., Wuhrer M. Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics. Electrophoresis 2011, 32(24):3456-3466. 10.1002/elps.201100247.
274. Zeng Z., Hincapie M., Pitteri S.J., Hanash S., Schalkwijk J., Hogan J.M., et al. A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome. Analytical Chemistry 2011, 83(12):4845-4854. 10.1021/ac2002802.
275. Zhang K., Sikut R., Hansson G.C. A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells. Cellular Immunology 1997, 176(2):158-165. 10.1006/cimm.1997.1085.
276. Zhao Q., Barclay M., Hilkens J., Guo X., Barrow H., Rhodes J.M., et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Molecular Cancer 2010, 9:154. 10.1186/1476-4598-9-154.
277. Zhao Q., Guo X., Nash G.B., Stone P.C., Hilkens J., Rhodes J.M., et al. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Research 2009, 69(17):6799-6806. 10.1158/0008-5472.CAN-09-1096.
278. Zhao Y.-P., Ruan C.-P., Wang H., Hu Z.-Q., Fang M., Gu X., et al. Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling. Cancer 2012, 118(3):639-650. 10.1002/cncr.26342.
279. Zhao Y.-Y., Takahashi M., Gu J.-G., Miyoshi E., Matsumoto A., Kitazume S., et al. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Science 2008, 99(7):1304-1310. 10.1111/j.1349-7006.2008.00839.x.
280. Zhuo Y., Chammas R., Bellis S.L. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. The Journal of Biological Chemistry 2008, 283(32):22177-22185. 10.1074/jbc.M8000015200.